Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Arch Biopartners Inc (ARCH.VN)

Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Income Statement for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 09/30

(Values in thousands)
  09-2024 06-2024 03-2024 12-2023 09-2023
Operating Expenses 1,031 768 1,055 703 -517
Operating Income -1,031 -768 -1,055 -703 517
Interest Expense 117 95 89 89 116
Other Income 44 -22 -4 9 -157
Pre-tax Income -1,104 -885 -1,149 -783 244
Net Income Continuous -1,104 -885 -1,149 -783 244
Net Income $-1,104 $-885 $-1,149 $-783 $244
EPS Basic Total Ops -0.02 -0.01 -0.02 -0.01 0.00
EPS Basic Continuous Ops -0.02 -0.01 -0.02 -0.01 0.00
EPS Diluted Total Ops -0.02 -0.01 -0.02 -0.01 0.00
EPS Diluted Continuous Ops -0.02 -0.01 -0.02 -0.01 0.00
EBITDA(a) $-987 $-789 $-1,060 $-695 $360
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.